RCMI Coordinating Center (RCMI CC) Header Logo

Gehan Devendra

Concepts (67)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Monocytes
1
2023
259
0.690
Why?
Shock, Septic
1
2019
20
0.630
Why?
Cardiotonic Agents
1
2019
37
0.630
Why?
Leukocytes, Mononuclear
2
2024
231
0.230
Why?
Pulmonary Fibrosis
1
2024
33
0.210
Why?
Pulmonary Surfactant-Associated Proteins
1
2002
2
0.190
Why?
Pulmonary Surfactants
1
2002
27
0.180
Why?
Lung Diseases
1
2002
61
0.180
Why?
Milrinone
1
2019
4
0.160
Why?
Dobutamine
1
2019
7
0.160
Why?
Epinephrine
1
2019
37
0.160
Why?
Pseudolymphoma
1
2019
5
0.160
Why?
Shock, Cardiogenic
1
2019
10
0.160
Why?
Cytokines
1
2023
611
0.150
Why?
Myocarditis
1
2019
21
0.150
Why?
Hospital Mortality
1
2019
192
0.140
Why?
Cross-Sectional Studies
1
2023
2764
0.120
Why?
Humans
8
2024
37697
0.110
Why?
Retrospective Studies
1
2019
2090
0.110
Why?
Pulmonary Embolism
2
2011
32
0.100
Why?
Endarterectomy
1
2011
1
0.090
Why?
Methylprednisolone
1
2011
17
0.090
Why?
Preoperative Care
1
2011
26
0.090
Why?
Lung Injury
1
2011
15
0.090
Why?
Thrombectomy
1
2011
13
0.090
Why?
Heparin, Low-Molecular-Weight
1
2007
8
0.070
Why?
Thrombocytopenia
1
2007
22
0.070
Why?
Heparin
1
2007
36
0.070
Why?
Anticoagulants
1
2007
104
0.060
Why?
Myeloid Cells
1
2024
29
0.050
Why?
Sequence Analysis, RNA
1
2024
105
0.050
Why?
Vascular Endothelial Growth Factor A
1
2024
161
0.050
Why?
Granulocytes
1
2022
28
0.050
Why?
Disease Progression
1
2024
622
0.040
Why?
Phenotype
1
2022
695
0.040
Why?
Ampicillin
1
2019
6
0.040
Why?
Dyspnea
1
2019
18
0.040
Why?
Lung
1
2002
451
0.040
Why?
Immunosuppressive Agents
1
2019
81
0.040
Why?
Cohort Studies
1
2022
1551
0.040
Why?
Electrocardiography
1
2019
165
0.040
Why?
Antiviral Agents
1
2019
163
0.030
Why?
Case-Control Studies
1
2019
1143
0.030
Why?
Hawaii
1
2019
1970
0.030
Why?
Injections, Intravenous
1
2011
62
0.020
Why?
Bronchoalveolar Lavage Fluid
1
2011
56
0.020
Why?
Interleukin-8
1
2011
61
0.020
Why?
Interleukin-10
1
2011
76
0.020
Why?
Glucocorticoids
1
2011
88
0.020
Why?
Double-Blind Method
1
2011
287
0.020
Why?
Interleukin-6
1
2011
154
0.020
Why?
Follow-Up Studies
1
2011
994
0.020
Why?
Dose-Response Relationship, Drug
1
2011
1043
0.020
Why?
Aged
1
2019
6921
0.020
Why?
Treatment Outcome
1
2011
1395
0.020
Why?
Venous Thrombosis
1
2007
28
0.020
Why?
Prospective Studies
1
2011
1417
0.020
Why?
Confidence Intervals
1
2007
153
0.020
Why?
Female
2
2019
21366
0.020
Why?
Randomized Controlled Trials as Topic
1
2007
269
0.020
Why?
Odds Ratio
1
2007
536
0.020
Why?
Animals
1
2002
15211
0.020
Why?
Incidence
1
2007
956
0.010
Why?
Risk Assessment
1
2007
763
0.010
Why?
Adult
1
2019
12013
0.010
Why?
Middle Aged
1
2011
10421
0.010
Why?
Male
1
2011
20418
0.010
Why?
Devendra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (67)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support